» School of Pharmacy Researchers

Onyeka Godwin, PhD
Onyeka Godwin, PhD
Post-Doctoral Fellow
Rinker Health Science Campus
(714) 516-5473
Dr. Onyeka Godwin joined the Chapman University School of Pharmacy as a Postdoctoral Fellow in August 2014. Dr. Godwin received his BS in Biotechnology, specializing in Pediatric & Adult Oncology-Cytogenetics. He has worked at the Laboratory Cooperation of American in Research Triangle Park, North Carolina; Emory University Hospital Medical Laboratory in Atlanta, Georgia, and Quest Diagnostic Laboratory in Chantilly, Virginia. While working at Emory University Hospital Oncology laboratory, Dr. Godwin has assisted in the complex trial and experimenting on a new testing procedure for multiple myeloma using magnetic cell sorting for plasma cells CD138. Dr. Godwin was involved in drafting the procedures for the plasma cells extraction afterwards.
Godwin earned his Ph.D. in Social and Administrative Pharmacy from Howard University, College of Pharmacy, Washington, DC. Dr. Godwin is trained in the area of Pharmacy Administration with the concentration in Pharmacoeconomics, Pharmacoepidemiology, and Health Economics Research.
Godwin was recognized as a Student Exemplar, during the Howard University 2014 Hood Celebration. Godwin also received the Chauncey I. Cooper Scholarship and Mordecai Wyatt Johnson, and was inducted into Rho Chi Honor Society, 2013.
Godwin co-authored the following unpublished studies: (a) Validation of the application of self-administered Clinical Cultural Competency Questionnaire (CCCQ) and the California Brief Multicultural Competency Scale (CBMCS) in the curriculum development, (b) Trends of Vitamin D Prescribing among Elderly Americans: Results from National Ambulatory Medical Care Surveys 2000 to 2009, (c) Predictive Factors of Pharmacy Satisfaction using a National Level Data in South Korea, (d) Compliance on the Consolidated Standards of Reporting Trials (CONSORT) guidelines in randomized controlled trials, and (f) Cost-Effectiveness Analysis of Nevirapine compared to Ritonavir-Boosted Lopinavir in HIV-Infected Children with Peripartum Nevirapine Exposure in Resource-Constrained areas, from Payer’s Perspective.
Sarmed  Kathem, PhD
Sarmed Kathem, PhD
Visiting Scholar
Rinker Health Science Campus
(714) 516-5463
Dr. Kathem joined the Chapman University School of Pharmacy as a Visiting Scholar in November 2014. He received his B.Sc. degree in Pharmacy from University of Baghdad in 1998. He worked in Ibn-Alnafees Hospital as a clinical pharmacist. Later, he changed his career to the academic field. He worked in the University of Baghdad College of Pharmacy as a teaching assistant (1999) then he received M.Sc. in pharmacology (2004) followed by Ph.D. in pharmacology (2012) from the University of Baghdad College of Pharmacy. He appointed as a tenure faculty in the University of Baghdad College of Pharmacy from 2005 until now.
Dr. Kathem enrolled in the primary cilia research group with Dr. Surya Nauli in the University of Toledo in 2012, then he also re-joined with Dr. Nauli to pursue his research in Chapman University in 2014.
Dr. Kathem is a faculty in the University of Baghdad, visiting scholar in Chapman University, member in professional societies (ASPET, Iraqi Pharmacists Syndicate), reviewer in scientific journals, and participating in many conferences and workshops.
Dr. Kathem’s previous research focused on the molecular components of primary cilia mechanosensory and chemosensory functions in endothelial cells. The research focused on the role primary cilia in coordinating the dopaminergic and NO signaling of endothelial cells in polycystic kidney disease. That research includes in vitro models and clinical studies. In addition, the role of primary cilia in planer cell polarity also explored in relation to polycystic kidney disease (PKD). The current research looking for more signaling pathways regulated by primary cilia in endothelial and renal epithelial cells, these signaling pathways expected to have pharmacological impact on PKD.
Dr. Kathem currently work with Chapman’s cilia research group led by Dr. Surya Nauli, their experimental and clinical research intending: 1) to increase our knowledge on the role of primary cilia in disease, specially the cardiovascular component of PKD like hypertension; 2) to find cilia-related molecular targets to be utilized for therapeutic purposes. Their research on primary cilia aiming to translate the experimental findings into clinical practice in an attempt to shed the light on the way to pharmacologically rescue primary cilia function or what is called ciliotherapy.
Siva Kolta, PhD
Siva Kolta, PhD
Post Doctoral Fellow
(714) 516-5464
Dr. Siva K Reddy Kotla joined the Chapman University School of Pharmacy as a Postdoctoral Fellow in December 2014 after submitting his PhD thesis in Organic Chemistry at University of Delhi (DU), Delhi, India.
After completion of MSc Organic Chemistry in 2004, Dr. Kotla worked in various pharmaceutical industries in India like AVRA Labs, Chembiotek and Jubilant Chemsys. After having seven years of rich experience in organic synthesis he joined as a Senior Research Fellow at the University of Delhi, a renowned central university in India in 2011. During his Ph.D. work, he focused on Transition-Metal-Catalyzed Novel Approaches for the Tandem Synthesis of Naphthyridines/Thienopyridines/Acridones/?-Carbolines and Isoquinolines from Alkynes and Double C-H activation methodologies for the construction of Polycyclic aromatic hydrocarbons (PAHs). He has authored and co-authored four peer-reviewed research publications in ACS journal.
N. Mallikarjuna  Reddy PhD
N. Mallikarjuna Reddy PhD
Post Doctoral Fellow
(714) 516-5461
Dr. Reddy joined the Chapman University School of Pharmacy as a Postdoctoral Fellow in March 2014 after submitting his PhD thesis in organic chemistry at Jawaharlal Nehru Technological University Hyderabad (JNTUH), Hyderabad, India.
After completion of MSc Organic Chemistry, Dr. Reddy qualified in the CSIR-JRF national level test conducted by Council of Scientific and Industrial Research, India. He joined as a Junior Research Fellow at the Indian Institute of Chemical Technology, a reputed institution in India. During his Ph.D. work, he synthesised various biologically active natural products.
Dr. Reddy was involved in the synthesis of natural products by using Prins cyclization reaction and was actively participated in the synthesis of various pheromone components. He has authored and co-authored eleven peer-reviewed research publications.
Naglaa Salem
Naglaa Salem
Visiting Researcher and Scholar
(401) 212-6720
Naglaa Salem joined the Chapman University School of Pharmacy at as an Affiliated Student Researcher in March 2014. She has been working on her PhD project under the supervision of Dr. Keykavous Parang since January 2013. Salem received her MSc in synthetic organic chemistry from the University Cairo in 2010. Previously she worked as a research assistant at National Research Centre, Giza, Egypt.
Salem’s research is focused on the synthesis and structure activity relationship of novel heterocyclic compounds for evaluation as antimicrobial, anticancer, and anti-inflammatory agents. She uses microwave-assisted synthesis to increase the reaction rate, yield, and purity. Previously she worked on chemical modifications of cellulose derivatives to improve their ability for heavy metal adsorption from aqueous solutions. Currently, her research is focused on chemical modification of water soluble chitosan and cellulose acetate and their application in the field of drug delivery and pharmaceutical formulations. Furthermore, she is involved in the synthesis of linear and cyclic peptides as a drug delivery systems and designing of new drug-peptide conjugates for efficient and targeted drug delivery to the cancer cells.
Pala Rajasekharreddy, PhD
Pala Rajasekharreddy, PhD
Post-Doctoral Fellow
Rinker Health Science Campus
(714) 516-5462
Dr. Pala Rajasekharreddy joined Chapman University School of Pharmacy in February 2015 as a Post-Doctoral researcher. He earned his PhD in Biological Sciences from Academy of Scientific and Innovative Research (AcSIR), New Delhi.
Dr. Pala is a Nano biotechnologist specialized in the Biological/Green synthesis of various metal and metal oxide nanoparticles with their application as drug delivery agents. After his post-graduation he was selected for ICMR-Research Fellowship under Biomedical Sciences in 2011 and during this period of his doctoral studies at CSIR-Indian Institute of Chemical Technology, India, he has earned handsome experience on the physical and chemical characterizations techniques of nanoparticles that are enveloped with various biologically active compounds such as protein, lipids and small molecular drugs for their biomedical applications.
Dr. Pala is a Nano biotechnologist specialized in the Biological/Green synthesis of various metal and metal oxide nanoparticles with their application as drug delivery agents. After his post-graduation he was selected for ICMR-Research Fellowship under Biomedical Sciences in 2011 and during this period of his doctoral studies at CSIR-Indian Institute of Chemical Technology, India, he has earned handsome experience on the physical and chemical characterizations techniques of nanoparticles that are enveloped with various biologically active compounds such as protein, lipids and small molecular drugs for their biomedical applications.
Current Research: Understanding primary cilia and their associated diseases by using different nanoparticles mediated therapeutic agents. Click here for more information on current research.
Amir N.  Shirazi, PhD
Amir N. Shirazi, PhD
Research Associate
(401) 874-7652
Dr. Amir Nasrolahi Shirazi joined the Chapman University School of Pharmacy as a Postdoctoral Research Associate in September, 2013. He received his PhD in pharmaceutical sciences from College of Pharmacy at the University of Rhode Island in August 2013.
Shirazi’s research documents the potential of nano-sized peptide-drug conjugates that could be used for different applications in pharmaceutical sciences. He is involved in several areas of pharmaceutical research including (1) Development of new nano drug delivery systems (DDS); (2) Development of novel prodrugs and multifunctional anticancer agents for improving ADME properties; (3) Design and evaluation of new peptide-based kinase inhibitors, and (4) Evaluation of anticancer activity of compounds by cell-based assays. Shirazi has a strong background in chemistry and biology.
Shirazi has received numerous awards at the University of Rhode Island, such as Graduate School Tuition Scholarship (2012), College of Pharmacy Graduate Student Research Excellence Award (2012), Enhancement of Graduate Research Awards (EGRA, 2010, 2011, and 2012), College of Pharmacy Foundation Award (2011), and College of Pharmacy Scholarship Endowment (2012). In May 2013, Dr. Shirazi was recognized as an outstanding researcher by the Department of Research and Economic Development at University of Rhode Island and awarded 2013 Graduate Research & Scholarship Excellence Award in Life Sciences, Physical Sciences and Engineering.
Shirazi has authored or co-authored more than 27 peer-reviewed research publications. He has also presented his research in more than 20 national and international scientific meetings. He is a member of American Chemical Society.